ラニビズマブの世界市場 2020年

• 英文タイトル：Global Ranibizumab Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114986 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、ラニビズマブの世界市場を調査対象にし、ラニビズマブの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（使い捨て式プレフィルドシリンジ、使い捨て式ガラスバイアル）、用途別分析（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Genentech、Novartis ・企業別売上、市場シェア ・ラニビズマブの地域別市場分析 ・ラニビズマブの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ラニビズマブのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ラニビズマブのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ラニビズマブの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ラニビズマブの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ラニビズマブの種類別市場規模2015-2020：使い捨て式プレフィルドシリンジ、使い捨て式ガラスバイアル ・ラニビズマブの用途別市場規模2015-2020：wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO ・ラニビズマブの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Ranibizumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Ranibizumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Ranibizumab market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ranibizumab market has been segmented into:
Single-use prefilled syringe
Single-use glass vial

By Application, Ranibizumab has been segmented into:
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ranibizumab market presented in the report. This section sheds light on the sales growth of different regional and country-level Ranibizumab markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ranibizumab market.

The report offers in-depth assessment of the growth and other aspects of the Ranibizumab market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Ranibizumab Market Share Analysis
Ranibizumab competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ranibizumab sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ranibizumab sales, revenue and market share for each player covered in this report.

The major players covered in Ranibizumab are:
Genentech
Novartis

レポート目次

---

1 Ranibizumab Market Overview
1.1 Product Overview and Scope of Ranibizumab
1.2 Classification of Ranibizumab by Type
1.2.1 Global Ranibizumab Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Ranibizumab Revenue Market Share by Type in 2019
1.2.3 Single-use prefilled syringe
1.2.4 Single-use glass vial
1.3 Global Ranibizumab Market by Application
1.3.1 Overview: Global Ranibizumab Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 wAMD
1.3.3 Diabetic Retinopathy (DR)
1.3.4 Diabetic Macular Edema (DME)
1.3.5 mCNV
1.3.6 RVO
1.4 Global Ranibizumab Market by Regions
1.4.1 Global Ranibizumab Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Ranibizumab (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Ranibizumab Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Ranibizumab Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ranibizumab Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Ranibizumab Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ranibizumab Status and Prospect (2015-2025)
2 Company Profiles
2.1 Genentech
2.1.1 Genentech Details
2.1.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genentech SWOT Analysis
2.1.4 Genentech Product and Services
2.1.5 Genentech Ranibizumab Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Ranibizumab Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Ranibizumab Players Market Share
3.2.2 Top 10 Ranibizumab Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Ranibizumab Revenue and Market Share by Regions
4.2 North America Ranibizumab Revenue and Growth Rate (2015-2020)
4.3 Europe Ranibizumab Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Ranibizumab Revenue and Growth Rate (2015-2020)
4.5 South America Ranibizumab Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Ranibizumab Revenue and Growth Rate (2015-2020)
5 North America Ranibizumab Revenue by Countries
5.1 North America Ranibizumab Revenue by Countries (2015-2020)
5.2 USA Ranibizumab Revenue and Growth Rate (2015-2020)
5.3 Canada Ranibizumab Revenue and Growth Rate (2015-2020)
5.4 Mexico Ranibizumab Revenue and Growth Rate (2015-2020)
6 Europe Ranibizumab Revenue by Countries
6.1 Europe Ranibizumab Revenue by Countries (2015-2020)
6.2 Germany Ranibizumab Revenue and Growth Rate (2015-2020)
6.3 UK Ranibizumab Revenue and Growth Rate (2015-2020)
6.4 France Ranibizumab Revenue and Growth Rate (2015-2020)
6.5 Russia Ranibizumab Revenue and Growth Rate (2015-2020)
6.6 Italy Ranibizumab Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Ranibizumab Revenue by Countries
7.1 Asia-Pacific Ranibizumab Revenue by Countries (2015-2020)
7.2 China Ranibizumab Revenue and Growth Rate (2015-2020)
7.3 Japan Ranibizumab Revenue and Growth Rate (2015-2020)
7.4 Korea Ranibizumab Revenue and Growth Rate (2015-2020)
7.5 India Ranibizumab Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Ranibizumab Revenue and Growth Rate (2015-2020)
8 South America Ranibizumab Revenue by Countries
8.1 South America Ranibizumab Revenue by Countries (2015-2020)
8.2 Brazil Ranibizumab Revenue and Growth Rate (2015-2020)
8.3 Argentina Ranibizumab Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Ranibizumab by Countries
9.1 Middle East & Africa Ranibizumab Revenue by Countries (2015-2020)
9.2 Saudi Arabia Ranibizumab Revenue and Growth Rate (2015-2020)
9.3 UAE Ranibizumab Revenue and Growth Rate (2015-2020)
9.4 Egypt Ranibizumab Revenue and Growth Rate (2015-2020)
9.5 South Africa Ranibizumab Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Ranibizumab Revenue and Market Share by Type (2015-2020)
10.2 Global Ranibizumab Market Forecast by Type (2019-2024)
10.3 Single-use prefilled syringe Revenue Growth Rate (2015-2025)
10.4 Single-use glass vial Revenue Growth Rate (2015-2025)
11 Global Ranibizumab Market Segment by Application
11.1 Global Ranibizumab Revenue Market Share by Application (2015-2020)
11.2 Ranibizumab Market Forecast by Application (2019-2024)
11.3 wAMD Revenue Growth (2015-2020)
11.4 Diabetic Retinopathy (DR) Revenue Growth (2015-2020)
11.5 Diabetic Macular Edema (DME) Revenue Growth (2015-2020)
11.6 mCNV Revenue Growth (2015-2020)
11.7 RVO Revenue Growth (2015-2020)
12 Global Ranibizumab Market Size Forecast (2021-2025)
12.1 Global Ranibizumab Market Size Forecast (2021-2025)
12.2 Global Ranibizumab Market Forecast by Regions (2021-2025)
12.3 North America Ranibizumab Revenue Market Forecast (2021-2025)
12.4 Europe Ranibizumab Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Ranibizumab Revenue Market Forecast (2021-2025)
12.6 South America Ranibizumab Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Ranibizumab Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Ranibizumab Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ranibizumab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ranibizumab Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Ranibizumab Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Genentech Corporate Information, Location and Competitors
Table 6. Genentech Ranibizumab Major Business
Table 7. Genentech Ranibizumab Total Revenue (USD Million) (2017-2018)
Table 8. Genentech SWOT Analysis
Table 9. Genentech Ranibizumab Product and Solutions
Table 10. Genentech Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Ranibizumab Major Business
Table 13. Novartis Ranibizumab Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Ranibizumab Product and Solutions
Table 16. Novartis Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Global Ranibizumab Revenue (Million USD) by Players (2015-2020)
Table 18. Global Ranibizumab Revenue Share by Players (2015-2020)
Table 19. Global Ranibizumab Revenue (Million USD) by Regions (2015-2020)
Table 20. Global Ranibizumab Revenue Market Share by Regions (2015-2020)
Table 21. North America Ranibizumab Revenue by Countries (2015-2020)
Table 22. North America Ranibizumab Revenue Market Share by Countries (2015-2020)
Table 23. Europe Ranibizumab Revenue (Million USD) by Countries (2015-2020)
Table 24. Asia-Pacific Ranibizumab Revenue (Million USD) by Countries (2015-2020)
Table 25. South America Ranibizumab Revenue by Countries (2015-2020)
Table 26. South America Ranibizumab Revenue Market Share by Countries (2015-2020)
Table 27. Middle East and Africa Ranibizumab Revenue (Million USD) by Countries (2015-2020)
Table 28. Middle East and Africa Ranibizumab Revenue Market Share by Countries (2015-2020)
Table 29. Global Ranibizumab Revenue (Million USD) by Type (2015-2020)
Table 30. Global Ranibizumab Revenue Share by Type (2015-2020)
Table 31. Global Ranibizumab Revenue Forecast by Type (2021-2025)
Table 32. Global Ranibizumab Revenue by Application (2015-2020)
Table 33. Global Ranibizumab Revenue Share by Application (2015-2020)
Table 34. Global Ranibizumab Revenue Forecast by Application (2021-2025)
Table 35. Global Ranibizumab Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Ranibizumab Picture
Figure 2. Global Ranibizumab Revenue Market Share by Type in 2019
Figure 3. Single-use prefilled syringe Picture
Figure 4. Single-use glass vial Picture
Figure 5. Ranibizumab Revenue Market Share by Application in 2019
Figure 6. wAMD Picture
Figure 7. Diabetic Retinopathy (DR) Picture
Figure 8. Diabetic Macular Edema (DME) Picture
Figure 9. mCNV Picture
Figure 10. RVO Picture
Figure 11. Global Ranibizumab Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Ranibizumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Ranibizumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Ranibizumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Ranibizumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Ranibizumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Ranibizumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Ranibizumab Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Ranibizumab Revenue Market Share in 2019
Figure 20. Global Top 10 Players Ranibizumab Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Ranibizumab Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Ranibizumab Revenue Market Share by Regions (2015-2020)
Figure 24. Global Ranibizumab Revenue Market Share by Regions in 2018
Figure 25. North America Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 26. Europe Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 28. South America Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 30. North America Ranibizumab Revenue Market Share by Countries (2015-2020)
Figure 31. North America Ranibizumab Revenue Market Share by Countries in 2019
Figure 32. USA Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 33. Canada Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 35. Europe Ranibizumab Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Ranibizumab Revenue Market Share by Countries in 2019
Figure 37. Germany Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 38. UK Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 39. France Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 40. Russia Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 41. Italy Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Ranibizumab Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Ranibizumab Revenue Market Share by Countries in 2019
Figure 44. China Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 45. Japan Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 46. Korea Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 47. India Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 49. South America Ranibizumab Revenue Market Share by Countries (2015-2020)
Figure 50. South America Ranibizumab Revenue Market Share by Countries in 2019
Figure 51. Brazil Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Ranibizumab Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Ranibizumab Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 56. UAE Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Ranibizumab Revenue and Growth Rate (2015-2020)
Figure 59. Global Ranibizumab Revenue Share by Type (2015-2020)
Figure 60. Global Ranibizumab Revenue Share by Type in 2019
Figure 61. Global Ranibizumab Market Share Forecast by Type (2021-2025)
Figure 62. Global Single-use prefilled syringe Revenue Growth Rate (2015-2020)
Figure 63. Global Single-use glass vial Revenue Growth Rate (2015-2020)
Figure 64. Global Ranibizumab Revenue Share by Application (2015-2020)
Figure 65. Global Ranibizumab Revenue Share by Application in 2019
Figure 66. Global Ranibizumab Market Share Forecast by Application (2021-2025)
Figure 67. Global wAMD Revenue Growth Rate (2015-2020)
Figure 68. Global Diabetic Retinopathy (DR) Revenue Growth Rate (2015-2020)
Figure 69. Global Diabetic Macular Edema (DME) Revenue Growth Rate (2015-2020)
Figure 70. Global mCNV Revenue Growth Rate (2015-2020)
Figure 71. Global RVO Revenue Growth Rate (2015-2020)
Figure 72. Global Ranibizumab Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Ranibizumab Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Ranibizumab Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Ranibizumab Revenue Market Forecast (2021-2025)
Figure 76. Europe Ranibizumab Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Ranibizumab Revenue Market Forecast (2021-2025)
Figure 78. South America Ranibizumab Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Ranibizumab Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---